Results 291 to 300 of about 307,887 (342)
Continuous glucose monitoring‐derived time in range is associated with changes in cognitive function test scores in Japanese patients with type 2 diabetes mellitus
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aims
Type 2 diabetes mellitus (T2DM) is known to be a risk factor for cognitive dysfunction and dementia. Time in range (TIR), which is derived from continuous glucose monitoring (CGM), has been widely used as an indicator of the quality of glycemic control. While cross‐sectional studies have reported an association between CGM‐derived TIR and Maki Inoue, Yoshiki Kusunoki, Mana Ohigashi, Keiko Osugi, Chikako Inoue, Akihito Otsuka, Daisuke Azuma, Hiroki Ikeda, Daisuke Tamada, Tadahiro Inagaki, Nobuaki Watanabe, Akio Miyoshi, Akinori Kanzaki, Manabu Kadoya, Kosuke Konishi, Hidenori Koyama, Hyogo Diabetes Hypoglycemia Cognition Complications (HDHCC) Study Group, Yoshiki Kusunoki, Mana Ohigashi, Keiko Osugi, Chikako Inoue, Maki Inoue, Kosuke Tamai, Takuya Nakagawa, Akiko Morimoto, Taku Tsunoda, Miki Kakutani, Yonekazu Kidawara, Akio Miyoshi, Akinori Kanzaki, Manabu Kadoya, Kosuke Konishi, Takuhito Shoji, Tomoyuki Katsuno, Hidenori Koyama, Akihito Otsuka, Shinya Makino, Nobuaki Watanabe, Tetsuhiro Kitamura, Daisuke Tamada, Masaru Usami, Masataka Kanyama, Hiroki Ikeda, Daisuke Azuma, Tadahiro Inagaki, Taku Tsunoda, Takeharu Sasaki, Toshihiro Matsuo, Hiroyuki Konya, Isao Hayashi, Kenji Kusunoki, Minoru Kubota, Hideki Ifuku, Takeshi Fukui, Shogo Kurebayashi, Hidenori Taniguchi, Tomoya Hamaguchi, Mitsuyoshi Namba +57 morewiley +1 more sourceEfficacy and safety of danuglipron (PF‐06882961) in adults with obesity: A randomized, placebo‐controlled, dose‐ranging phase 2b study
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aims
This randomized, double‐blind, placebo‐controlled Phase 2b study aimed to assess the efficacy, safety, and tolerability of danuglipron (PF‐06882961), an oral small‐molecule glucagon‐like peptide‐1 (GLP‐1) receptor agonist, in adults with obesity. Materials and Methods
Eligible participants (aged 18–75 years; with obesity, without diabetes)Clare Buckeridge, Sonia Cobain, Harold E. Bays, Osamu Matsuoka, Yasushi Fukushima, Patricia Halstead, Nikolaos Tsamandouras, Nicole Sherry, Donal N. Gorman, Aditi R. Saxena +9 morewiley +1 more sourceLong‐term preservation of kidney function with SGLT‐2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aims
Chronic kidney disease (CKD) is a prevalent and serious complication of type 2 diabetes (T2D). This study aims to evaluate kidney outcomes in a real‐world cohort of patients with T2D and CKD who received SGLT2 inhibitors (SGLT2i) or other glucose‐lowering medications (GLM).Gian Paolo Fadini, Enrico Longato, Mario Luca Morieri, Fabio Broglio, Gianluca Aimaretti, Giuseppina T. Russo, Roberto Anichini, Mariangela Ghiani, Angelo Avogaro, Anna Solini, DARWIN‐Renal Study Investigators, Maria Pompea Antonia Baldassarre, Gloria Formoso, Agostino Consoli, Sara Morgante, Antonella Zugaro, Marco Giorgio Baroni, Francesco Andreozzi, Adriano Gatti, Stefano De Riu, Andrea Del Buono, Raffaella Aldigeri, Riccardo Bonadonna, Alessandra Dei Cas, Angela Vazzana, Monica Antonini, Valentina Moretti, Patrizia Li Volsi, Miranda Cesare, Giorgio Zanette, Silvia Carletti, Paola D'Angelo, Gaetano Leto, Frida Leonetti, Ernesto Maddaloni, Raffaella Buzzetti, Simona Frontoni, Maria Gisella Cavallo, Ilaria Barchetta, Susanna Morano, Tiziana Filardi, Umberto Capece, Andrea Giaccari, Antonio C. Bossi, Giancarla Meregalli, Fabrizio Querci, Alessia Gaglio, Veronica Resi, Emanuela Orsi, Stefano Fazion, Ivano G. Franzetti, Cesare Berra, Silvia Manfrini, Gabriella Garrapa, Giulio Lucarelli, Lara Riccialdelli, Elena Tortato, Marco Zavattaro, Gianluca Aimaretti, Franco Cavalot, Guglielmo Beccuti, Fabio Broglio, Bruno Fattor, Giuliana Cazzetta, Olga Lamacchia, Anna Rauseo, Salvatore De Cosmo, Rosella Cau, Mariangela Ghiani, Antonino Di Benedetto, Antonino Di Pino, Salvatore Piro, Francesco Purrello, Lucia Frittitta, Agostino Milluzzo, Giuseppina Russo, Anna Solini, Monia Garofolo, Giuseppe Penno, Stefano Del Prato, Roberto Anichini, Gian Paolo Fadini, Angelo Avogaro, Mauro Rigato, Agostino Paccagnella, Marco Strazzabosco, Massimo Cigolini, Enzo Bonora +87 morewiley +1 more sourceCellular composition and transcriptomics of subcutaneous adipose tissue linked to blood glycated haemoglobin
European Journal of Clinical Investigation, EarlyView.Immune cell overrepresentation in SAT in subjects with high HbA1c was accompanied by decreased adipocytes, smooth muscle, pericytes and other endothelial cell numbers. Immune system and inflammation‐related pathways, cellular senescence and telomere‐related pathways, nervous system development and extracellular matrix organization were associated with ...Sara Paulí, Núria Oliveras‐Cañellas, José Maria Moreno‐Navarrete, Anna Castells‐Nobau, Francisco José Ortega, Jose Ignacio Rodriguez‐Hermosa, Ernesto Castro, Birong Zhang, You Zhou, Javier Gómez‐Ambrosi, Ana Belén Crujeiras, Oriol Alberto Rangel‐Zuñiga, Lourdes Garrido‐Sanchez, Sara Becerril, María Pardo, Juan Luis Romero‐Cabrera, Carolina Gutierrez‐Repiso, Marcos C. Carreira, Manuel Macias‐Gonzalez, Miguel Ángel Martinez‐Olmos, Gema Frühbeck, Luisa Maria Seoane, José López‐Miranda, Francisco José Tinahones, Carlos Diéguez, Jordi Mayneris‐Perxachs, José Manuel Fernández‐Real +26 morewiley +1 more sourceDo the Types of Dietary Carbohydrate and Protein Affect Postprandial Glycemia in Type 1 Diabetes? [PDF]
NutrientsLi X, Wainwright A, Fio CZ, Brodie S, Alexander K, McGill M, Duke SA, Fulcher G, Twigg S, Wong J, Brand-Miller J, Steil GM, Bell KJ. +12 moreeuropepmc +1 more source